HEALTH CATALYST INC - NOTE 2.500% 4/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q2 2025

Type / Class
Debt / NOTE 2.500% 4/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of HEALTH CATALYST INC - NOTE 2.500% 4/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$229,496,329 0
2025 Q1 $208,026,606 $229,496,329 -$2,552,048 99.63% 15
2024 Q4 $210,652,581 $229,745,981 -$20,691,237 98.84% 16
2024 Q3 $232,571,491 $249,663,826 +$23,297,081 98.33% 14
2024 Q2 $209,476,086 $224,496,908 +$171,201 97.44% 13
2024 Q1 $209,455,161 $221,524,880 -$18,955,409,001 95.5% 11
2023 Q4 $229,581,000 $218,667,672 +$18,330,999 95.32% 12
2023 Q3 $210,375,626 $220,007,851 -$2,767,941 96.19% 14
2023 Q2 $210,410,626 $223,444,335 +$1,457,797 96.18% 19
2023 Q1 $210,811,146 $211,658,136 -$1,091,314 91.75% 21
2022 Q4 $209,972,536 $187,111,096 +$5,834,187 87.32% 24
2022 Q3 $203,317,536 $193,939,262 -$878,151 85.38% 20
2022 Q2 $217,379,946 $200,524,000 -$10,594,792 89.48% 20
2022 Q1 $229,417,000 $261,454,000 -$5,894,586 113.82% 17
2021 Q4 $230,000,000 $334,495,000 +$3,170,937 145.22% 14
2021 Q3 $222,466,000 $389,683,000 +$20,253,578 175.17% 18
2021 Q2 $210,925,000 $404,767,000 +$404,767,200 191.83% 17